Skip to main content
SpringerLink
Log in

Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney disease

  • Letter to the Editor
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Chrispijn M, Nevens F, Gevers TJ, Vanslembrouck R, van Oijen MG, Coudyzer W, et al. The long-term outcome of patients with polycystic liver disease treated with lanreotide. Aliment Pharmacol Ther. 2012;35(2):266–74.

    Article  CAS  PubMed  Google Scholar 

  2. Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol. 2008;19(3):631–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Walz G, Budde K, Mannaa M, Nurnberger J, Wanner C, Sommerer C, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. New Engl J Med. 2010;363(9):830–40.

    Article  CAS  PubMed  Google Scholar 

  4. Chrispijn M, Gevers TJ, Hol JC, Monshouwer R, Dekker HM, Drenth JP. Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial. J Hepatol. 2013;59(1):153–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

On behalf of the everolimus in autosomal dominant polycystic kidney disease trial investigators.

Conflict of interest

Stefan Zschiedrich has no conflict of interest. Klemens Budde is a consultant for Novartis, and has received research funding from Novartis. Gerd Walz is a consultant for Novartis, and a member of the ADPKD advisory board for Otsuka.

Author information

Authors and Affiliations

  1. Renal Division, Department of Medicine, University Hospital Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany

    Stefan Zschiedrich & Gerd Walz

  2. Renal Division, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany

    Klemens Budde

Authors
  1. Stefan Zschiedrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klemens Budde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerd Walz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerd Walz.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zschiedrich, S., Budde, K. & Walz, G. Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney disease. Clin Exp Nephrol 19, 757–758 (2015). https://doi.org/10.1007/s10157-014-1059-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-014-1059-x

Keywords

Search

Navigation